GROSSMAN JERROLD B purchased 1.2% of their position (6.40K shares) of ADMA BIOLOGICS, INC. on the open market
Open‑market purchase worth $50.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/28/2026ACC: 0001140361-26-023127
+6.40K
Net shares
Net buyer
$50.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.40K
Price / share
$7.91
Trade value
$50.62K
% of position
1.2%
5/27/2026
513.88K→520.28K
Total
Net shares
+6.40K
Net value
$50.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2026 | P · Purchase | +6.40K | $7.91 | $50.62K | 1.2% | 513.88K | 520.28K |
| Total | +6.40K | $50.62K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned22.86K
Common Stock
IndirectShares owned38.29K
Common Stock
IndirectShares owned175.00
Common Stock
IndirectShares owned31.38K
Total
92.71K indirect92.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22.86K | Indirect |
| Common Stock | 38.29K | Indirect |
| Common Stock | 175.00 | Indirect |
| Common Stock | 31.38K | Indirect |
| Total | 92.71K | 92.71K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported